Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 41% ± 23% | |
| astrocyte | 8 studies | 28% ± 12% | |
| fibroblast | 8 studies | 27% ± 12% | |
| microglial cell | 7 studies | 27% ± 6% | |
| GABAergic neuron | 6 studies | 42% ± 17% | |
| endothelial cell | 6 studies | 32% ± 10% | |
| interneuron | 5 studies | 35% ± 16% | |
| retinal cone cell | 5 studies | 31% ± 9% | |
| macrophage | 5 studies | 29% ± 6% | |
| granule cell | 4 studies | 29% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 6% | |
| rod bipolar cell | 3 studies | 22% ± 5% | |
| retinal pigment epithelial cell | 3 studies | 27% ± 9% | |
| ependymal cell | 3 studies | 36% ± 18% | |
| pericyte | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 33% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2810.29 | 245 / 245 | 100% | 23.10 | 500 / 502 |
| thymus | 100% | 4067.03 | 653 / 653 | 97% | 23.35 | 589 / 605 |
| brain | 97% | 2386.45 | 2550 / 2642 | 98% | 25.44 | 688 / 705 |
| adrenal gland | 100% | 2304.85 | 258 / 258 | 86% | 11.21 | 198 / 230 |
| breast | 99% | 1495.82 | 455 / 459 | 81% | 8.30 | 909 / 1118 |
| lung | 100% | 1964.91 | 577 / 578 | 66% | 4.79 | 763 / 1155 |
| skin | 80% | 965.58 | 1456 / 1809 | 80% | 8.69 | 378 / 472 |
| bladder | 100% | 2460.86 | 21 / 21 | 57% | 17.21 | 287 / 504 |
| uterus | 100% | 2878.55 | 170 / 170 | 55% | 7.27 | 252 / 459 |
| liver | 98% | 1846.80 | 221 / 226 | 53% | 4.93 | 215 / 406 |
| ovary | 100% | 3121.16 | 180 / 180 | 50% | 3.28 | 216 / 430 |
| kidney | 100% | 3455.25 | 89 / 89 | 46% | 5.68 | 416 / 901 |
| stomach | 92% | 1416.88 | 331 / 359 | 51% | 4.47 | 147 / 286 |
| esophagus | 91% | 1795.85 | 1314 / 1445 | 41% | 2.67 | 75 / 183 |
| intestine | 94% | 1678.64 | 911 / 966 | 37% | 2.52 | 195 / 527 |
| pancreas | 34% | 188.38 | 110 / 328 | 85% | 8.91 | 152 / 178 |
| spleen | 100% | 2950.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2389.28 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1820.68 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1148.89 | 827 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 61% | 6.49 | 49 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 3.56 | 17 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 2.24 | 21 / 45 |
| muscle | 37% | 225.07 | 298 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 16% | 97.56 | 149 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_1904382 | Biological process | mannose trimming involved in glycoprotein ERAD pathway |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0004571 | Molecular function | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAN1C1 |
| Protein name | alpha-1,2-Mannosidase (EC 3.2.1.-) Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC (EC 3.2.1.113) (HMIC) (Mannosidase alpha class 1C member 1) (Processing alpha-1,2-mannosidase IC) (Alpha-1,2-mannosidase IC) |
| Synonyms | MAN1A3 MAN1C |
| Description | FUNCTION: Involved in the maturation of Asn-linked oligosaccharides. Trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce first Man(8)GlcNAc(2) then Man(6)GlcNAc and a small amount of Man(5)GlcNAc. |
| Accessions | A6NGN6 Q9NR34 ENST00000374329.1 ENST00000263979.7 ENST00000611903.4 A0A087WZ31 B1AJZ5 ENST00000374332.9 |